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Abstract
Background: Alzheimer’s disease (AD) and age-related macular degeneration (AMD) share several pathological
features including b-amyloid (Ab) peptide accumulation, oxidative damage, and cell death. The causes of AD and
AMD are not known but several studies suggest disturbances in cholesterol metabolism as a culprit of these
diseases. We have recently shown that the cholesterol oxidation metabolite 27-hydroxycholesterol (27-OHC) causes
AD-like pathology in human neuroblastoma SH-SY5Y cells and in organotypic hippocampal slices. However, the
extent to which and the mechanisms by which 27-OHC may also cause pathological hallmarks related to AMD are
ill-defined. In this study, the effects of 27-OHC on AMD-related pathology were determined in ARPE-19 cells. These
cells have structural and functional properties relevant to retinal pigmented epithelial cells, a target in the course
of AMD.
Methods: ARPE-19 cells were treated with 0, 10 or 25 μM 27-OHC for 24 hours. Levels of Ab peptide,
mitochondrial and endoplasmic reticulum (ER) stress markers, Ca
2+ homeostasis, glutathione depletion, reactive
oxygen species (ROS) generation, inflammation and cell death were assessed using ELISA, Western blot,
immunocytochemistry, and specific assays.
Results: 27-OHC dose-dependently increased Ab peptide production, increased levels of ER stress specific markers
caspase 12 and gadd153 (also called CHOP), reduced mitochondrial membrane potential, triggered Ca
2+
dyshomeostasis, increased levels of the nuclear factor B (NFB) and heme-oxygenase 1 (HO-1), two proteins
activated by oxidative stress. Additionally, 27-OHC caused glutathione depletion, ROS generation, inflammation and
apoptotic-mediated cell death.
Conclusions: The cholesterol metabolite 27-OHC is toxic to RPE cells. The deleterious effects of this oxysterol
ranged from Ab accumulation to oxidative cell damage. Our results suggest that high levels of 27-OHC may
represent a common pathogenic factor for both AMD and AD.
Background
Age-related macular degeneration (AMD) is the most
common cause of irreversible vision loss in elderly popula-
tion [1]. This disease is characterized by a progressive cell
damage that targets the choroid, retinal pigment epithe-
lium (RPE) and retina. Accumulation of drusen in the
extracellular compartment between the choroid and the
RPE is an early event in the course of AMD [2]. Drusen
are composed of acute phase proteins, complement com-
ponents, apolipoproteins, lipids, polysaccharides along
with various other molecules [3-5]. Intriguingly, AMD has
many pathological features that are common to Alzhei-
mer’s disease (AD), including the deposition of b-amyloid
(Ab) peptide [6]. Ab is suggested to play a key role in AD
pathogenesis by triggering oxidative stress, inflammation
and cell death [7]. Ab accumulation has also been demon-
strated to be associated with drusen in eyes from AMD
patients [8-10], mice models for AMD [11] and in RPE
cells [12]. Recent studies from our laboratory have shown
that the oxysterol 27-hydroxycholesterol (27-OHC) causes
AD-like pathology by increasing Ab production and
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any medium, provided the original work is properly cited.triggers apoptotic cell death in human neuroblastoma SH-
SY5Y cells [13,14] and in organotypic slices from rabbit
hippocampus [15,16]. However, the extent to which and
the mechanisms by which 27-OHC may also cause Ab
accumulation and cell death in in vitro model that is rele-
vant to retinal pigment epithelial cells and AMD studies
are lacking.
Similar to AD, the causes of AMD are not fully under-
stood. Several lines of evidence suggest that genetic pre-
disposition and environmental as well as dietary factors
may contribute to the pathogenesis of these two pro-
gressive degenerative disorders. Recent epidemiological
studies have demonstrated that high plasma cholesterol
levels are associated with a high risk for AD [17]. Like-
wise, high intake of cholesterol and saturated fat is asso-
ciated with increased AMD [18]. Cholesterol (free and
esterified) is highly distributed in the human drusen
[5,19,20]. The source of the cholesterol that accumulates
in the retina is suggested to derive from both local cells
and plasma origins [4,21-23]. Currently, the mechanisms
by which cholesterol may increase the incidence of AD
or AMD are not clear. Several lines of evidence suggest
that oxidized cholesterol metabolites (oxysterols) may be
the link by which cholesterol contributes to the patho-
genesis of AD [24]. The oxysterol pathway has also been
proposed as a unifying hypothesis for the cause of AMD
[25-27].
Oxysterols are oxidation products of cholesterol that
result from either autoxidation or enzymatic oxidation.
While 7-ketocholesterol is the major oxysterol generated
by autoxidation on the B hydrocarbon ring of choles-
terol, 24-hydroxycholesterol, 25-hydroxycholesterol and
27-hydroxycholesterol are major oxysterols produced by
enzymatic oxidation on the lateral chain of the choles-
terol structure. Oxysterols have diverse physiological
and biochemical functions ranging from regulation of
cholesterol homeostasis to regulation of nuclear recep-
tors [26-28]. However, abnormal oxysterol levels can
cause oxidative stress, inflammation and apoptotic cell
death [25,28-32].
In this study, we determined in the human RPE cell
line ARPE-19 the effects of 27-OHC on pathological
hallmarks that are common to both AMD and AD. We
have specifically determined levels of Ab and b-site of
APP cleaving enzyme (BACE-1), which initiates Ab pro-
duction, caspase 12 and gadd153 as markers of ER
stress, mitochondrial membrane potential as a marker of
mitochondrial stress, the nuclear factor B( N F B) and
heme-oxygenase 1 (HO-1) two proteins activated by oxi-
dative stress, ROS generation and glutathione depletion
and TNF-a as marker of inflammation. Additionally,
calcium homeostasis, cytotoxicity and cell death assays
were also carried out.
Methods
Cells and Treatments
ARPE-19 cells (American Type Culture Collection,
Manassas, VA) were grown in DMEM/F12 Glutamax
media with 10% FBS and standard antibiotics (100 IU/
mL penicillin, and 100 μg/mL streptomycin, Sigma,
St. Louis, MO) in a 5% CO2, 37°C incubator. Cells were
seeded in 75-cm
2 flasks, 6-well plates or 96-well plates.
All cell culture reagents were obtained from Invitrogen,
Carlsbad, CA. 27-OHC was obtained from Medical Iso-
topes Inc, Pelham, NH. Stock solutions of 27-OHC were
prepared in 100% ethanol and stored at -70°C. Working
concentrations were prepared by dissolving 27-OHC
stock solution in media. When cells reached confluency,
they were incubated with 0, 10 or 25 μM2 7 - O H Ci n
culture media for 24 hrs, time by which 27-OHC
increases Ab levels in SH-SY5Y cells [13]. Experiments
were carried out in triplicate. The concentrations of the
2 7 - O H Cu s e di nt h ep r e s e n ts t u d ya r et h es a m ea s
t h o s ew ed e m o n s t r a t e dt oc a u s eA D - l i k ep a t h o l o g yi n
human neuroblastoma cells and in organotypic slices
[13,15]. Joffre and colleagues have used concentrations
up to 50 μM of 7-ketocholesterol, 24-hydroxycholes-
terol, and 25-hydroxycholesterol [30].
Quantification of Ab by Enzyme-Linked Immunosorbent
Assay (ELISA)
Cells were treated with 27-OHC for 24 hrs. Spent media
was collected, protease and phosphatase inhibitors cock-
tail (Thermo Scientific, Rockford, IL) was added. The
media was centrifuged at 16,000 × g for 5 min at 4°C.
100 μL of supernatant was used for Ab1-42 and Ab1-40
quantification by colorimetric sandwich ELISA (Cov-
ance, Denver, PA) according to the manufacturer’s
instructions and as we have previously described [13].
Ab1-42 and Ab1-40 levels were expressed in pg/mL.
Western Blot Analysis
After 24 hrs treatment with 27-OHC, cells were har-
vested on ice and homogenized in a mammalian protein
extraction reagent (M-PER, Thermo Scientific, Rockford,
IL) supplemented with protease and phosphatase inhibi-
tors. Nuclear extracts for NFB were prepared by using
NE-PER extraction kit (Thermo Scientific, Rockford, IL).
Protein concentrations were determined with bicincho-
ninic acid (BCA) protein assay reagent. Proteins (10 μg)
were separated on SDS-PAGE gels followed by transfer
onto a polyvinylidene difluoride (PVDF) membrane
(Biorad, Herculus, CA) and incubation with antibodies
to BACE-1 (Mouse, 1:1000, Millipore, Bedford, MD),
caspase 12 (Rat, 1:1000, Abcam, Cambridge, MA),
gadd153 (Mouse, 1:1000, Abcam, Cambridge, MA), and
H O - 1( M o u s e ,1 : 5 0 0 ,A s s a yD e s i g n s ,A n nA r b o r ,M I ) .
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C r u z ,C A )w a su s e da sag e ll o a d i n gc o n t r o l .5μgo f
nuclear extracts were used for NFB( N F Bp 6 5 ;
Mouse, 1:100, Santa Cruz Biotechnology, Santa Cruz,
CA) and lamin (Rabbit, 1:500, Cell Signaling Technol-
ogy, Inc. Danvers, MA) was used as loading control. For
antibodies of mouse origin, goat anti-mouse secondary
antibody conjugated with horseradish peroxidise (HRP)
was used (1:5000, Biorad, Herculus, CA). For caspase12,
goat anti-rat secondary was used (1:2500, Santa Cruz
Biotechnology) and for lamin, goat anti-rabbit secondary
antibody (1:5000, Biorad) was applied. The blots were
developed with enhanced chemiluminescence
(Immmun-star HRP chemiluminescent kit, Bio-Rad,
Herculus, CA). Bands were visualized on a PVDF mem-
brane and analyzed by LabWorks 4.5 software on Ultra
Violet Products (UVP) Bioimaging System (Upland,
CA). Results were quantified by densitometry normal-
ized to b-actin or lamin and analyzed as total integrated
densitometric values (arbitrary units).
Confocal Microscopy
ARPE-19 cells were grown on collagen coated coverslips
and treated with 27-OHC for 24 hrs. After incubation
cells were washed with PBS, fixed in 4% paraformalde-
hyde, blocked with 5% normal goat serum and incu-
bated overnight at 4°C with monoclonal mouse
antibodies to gadd153 (1:250, Abcam, Cambridge, MA)
or NFB p65 (1:250, Santa Cruz Biotechnology, Santa
Cruz, CA). Cells were washed in PBS, incubated with
secondary antibody conjugated to Alexa fluor-488
(Molecular Probes, Inc., Eugene, OR) for 1 hour at
room temperature, washed with PBS, mounted with
Vectashield containing DAPI (Vector Laboratories Inc,
Burlingame, CA), and visualized with a Zeiss LSM 510
META confocal system coupled to a Zeiss Axiophot 200
inverted epifluorescence microscope. Imaging was per-
formed with a 63X oil immersion objective.
Calcium Imaging
Cells were cultured on 35 mm glass bottom culture
dishes (MatTek Corp, Ashland, MA) and incubated with
0, 10 or 25 μM of 27-OHC for 24 hrs. To measure
intracellular Ca
2+, cells were loaded with 2 μMf u r a -
2AM (Calbiochem, La Jolla, CA) for 45 min at 37°C
under an atmosphere of 5% CO2-95% air, washed three
times with Ca
2+-free SES buffer [33]. For fluorescence
measurements, the fluorescence intensity of Fura-2AM
-loaded cells were monitored using a CCD camera-
based imaging system (Compix Inc, Cranberry, PA)
mounted on an Olympus XL70 inverted microscope
equipped with an Olympus 40× (1.3 NA) fluor objective.
A monochrometer dual wavelength enabled alternative
excitation at 340 and 380 nm, whereas the emission
fluorescence was monitored at 510 nm with an Orka
imaging camera (Hamamatsu). The images of multiple
cells collected at each excitation wavelength were pro-
cessed using the Ca
2+ imaging, PCI software (Compix
Inc., Cranbery, PA) to provide ratios of Fura-2 fluores-
cence from excitation at 340 nm to that of excitation at
380 nm (F340/F380).
Glutathione Depletion, ROS Production, Mitochondrial
Membrane Potential, TNF-a and Cytotoxicity Assays
Equal numbers of cells were seeded in 96-well plates.
Cells were treated with 27-OHC for 24 hrs and media
was collected. A luminescent based GSH-Glo Assay
(Promega, Madison, WI) was used for quantification of
glutathione in cells. The intracellular production of ROS
was measured using Dichlorofluorescein diacetate
(DCFH-DA) assay (Sigma, St. Louis, MO). JC-1 Mito-
chondrial Membrane Potential Detection kit was used to
measure mitochondrial membrane potential changes in
c e l l s( B i o t i u m ,H a y w a r d ,C A ) .T h eI n v i t r o g e nM o u s e
Tumor Necrosis Factor-a (Ms TNF-a)E L I S Aw a su s e d
for the quantitative determination of TNF-a. Cytotoxi-
city assay was performed using Cyto Tox-ONE Homo-
genous membrane integrity assay (Promega). All the
assays were performed according to the manufacturer’s
instructions.
TUNEL Assay
The DeadEnd™ Fluorometric TUNEL System (Promega)
was used for detection of apoptotic cells. ARPE-19 cells
were fixed with 4% paraformaldehyde at room tempera-
ture, washed with PBS, permeabilized with 0.1% Triton
X-100, and labelled according to manufacturer’s
instructions.
Statistical analysis
Data was analyzed for statistical significance using analy-
sis of variance (ANOVA) followed by Dunnett Multiple
Comparison Test with GraphPad Prism software 4.01.
All values obtained from the three different experiments
were expressed as mean value ± SEM. Comparisons
were considered significant at p < 0.05.
Results
27-OHC increased Ab levels
Ab is an important component of plaques in Alzhei-
mer’sd i s e a s ea n dd r u s e nd e p o s i t si nA M D .A b1-42 and
Ab1-40 are the two major peptides that increase in AD.
T h eE L I S Aa s s a yf o rA b quantification (Figure 1a)
showed that the ARPE-19 cells express basal levels of
Ab1-42 and Ab1-40. Treatment with 27-OHC at 10 and
25 μM for 24 hrs significantly increased Ab1-42 but not
Ab1-40 levels in these cells. The magnitude of increase
in Ab1-42 levels is similar with 10 μMa n d2 5μMo f
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increased the levels of BACE-1 enzyme (Figure 1b), sug-
gesting that the increased levels of Ab1-42 derive, at
least in part, from an increase in the rate of production
of this peptide through the processing of b-amyloid pre-
cursor protein by BACE-1.
The immunocytochemistry using 6E10 antibody that
detects Ab peptides also showed an increase in the Ab
immunoreactivity with both 10 μMa n d2 5μMo f2 7 -
OHC compared to untreated cells (Figure 1c). The Ab
staining appeared to be mostly perinuclear. The immu-
nocytochemistry results confirmed the ELISA results
showing increased Ab1-42 levels. Increased Ab1-42 pep-
tide levels in the ARPE-19 cells could cause oxidative
damage to these cells, as high levels of this peptide
either soluble or insoluble form is toxic to cells.
27-OHC disturbed Ca
2+ homeostasis and caused ER stress
Ca
2+ is essential for cell functioning, and cell survival
depends on the maintenance of Ca
2+ homeostasis [34].
Disruptions of Ca
2+ homeostasis result in the develop-
ment of the ER stress response which can compromise
cell survival. Our results showed that addition of thapsi-
gargin (Tg, 2 μM), which initiates release of Ca
2+ from
the internal ER stores (in Ca
2+ free media) showed a sig-
nificant decrease in ER Ca
2+ content in cells treated
with either 10 or 25 μMo f2 7 - O H C( F i g u r e2 a - c ) .
Importantly, addition of 1mM Ca
2+ externally showed a
robust increase in cytosolic Ca
2+ levels in control cells.
However, cells treated with 10 or 25 μM2 7 - O H C
showed a gradual decrease in Ca
2+ entry (40-50%
decrease). Mean Ca
2+ influxes from 90-120 individual
cells are shown as bar graph in Figure 2d. Basal Ca
2+
Figure 1 27-OHC increased Ab production. Treatment of ARPE-19 cells with 10 μM and 25 μM 27-OHC for 24 hrs increased Ab1-42 but not
Ab1-40 levels (a). Levels of BACE-1, the enzyme that initiates the generation of Ab, are also increased following treatment with 27-OHC (b).
Immunocytochemistry with 6E10, an antibody that detects Ab, shows increased staining with 27-OHC (green); DAPI (blue) was used as a nuclear
counterstain (c). *p < 0.05, **p < 0.01 vs control; Bar, 20 μm.
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2+ without
Tg stimulation) was not altered (data not shown). Over-
all, these data demonstrate that treatment of the cells
with 27-OHC leads to a decrease in intracellular Ca
2+
entry and thus decreased ER Ca
2+. This could lead to
ER stress, since Ca
2+ entry through the plasma mem-
brane is essential for the refilling of the ER store.
As a result of ER stress, caspase 12 is activated and
can lead to apoptotic cell death [35]. Our Western blot
results showed that 27-OHC treatment increased the
Figure 2 Ca
2+ homeostasis is disturbed by 27-OHC.C a
2+ imaging was performed in the presence of thapsigargin (Tg; 2 μMi naC a
2+-free
media) in control ARPE-19 cells (a) or cells treated with 10 μM (b) or 25 μM 27-OHC (c). Ca
2+ influx was measured by the addition of 1 mM Ca
2
+ externally and traces shown here are averages of 30-40 cells in each condition (d). Bar graph indicates the mean values of the first peak (ER
calcium release) and second peak (calcium entry). *p < 0.05 vs control.
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10 μM (Figure 3a). Sustained ER stress leads to activa-
tion of gadd153 which can cause cell-cycle arrest and/or
apoptosis. Our results show that 27-OHC increased
levels of gadd153 at both 10 and 25 μM concentrations
(Figure 3b). The confocal microscopy imaging revealed
an increase in the number of nuclei that are gadd153-
positive on treatment with 25 μM 27-OHC treatment
(Figure 3c, arrows). The immunocytochemistry results
confirmed the activation of gadd153 and its transloca-
tion into the nucleus.
TNF-a is a multifunctional pro-inflammatory cytokine
that is viewed as a classic regulator of cell death and is
also activated by ER stress [36]. TNF-a is also an activa-
tor of NF-B. Our results show that 27-OHC, at 25 μM
but not at 10 μM ,i n d u c e sa ni n c r e a s ei nT N F - a levels
as determined by an ELISA assay (Figure 4a). Our
results suggest that treatment with 27-OHC is asso-
ciated with inflammatory responses.
NFB can be activated by ER stress and can exert
either cytoprotective or cytotoxic effects depending on
the type of stimulus and duration [37]. Active NFBi s
known to translocate to the nucleus [38]. Here we
showed that NFB levels in the nucleus are increased in
the 27-OHC treated cells (Figure 4b). The immunocyto-
chemistry with antibody to NFB further showed an
emergence of nuclear staining for NFBw i t h2 7 - O H C
treatment (Figure 4c, arrows).
27-OHC-induced oxidative damage
The glutathione system is the main redox control sys-
tem of the cell. It includes reduced glutathione (GSH)
and oxidized glutathione (GSSG). Treatment with 10
μMo r2 5μM 27-OHC caused a significant reduction in
GSH levels (Figure 5a). These results suggest that
27-OHC reduced the anti-oxidant potential of cells,
thereby increasing cell susceptibility to oxidative
damage. We also determined the extent to which treat-
ment with 27-OHC caused oxidative stress in ARPE-19
cells by increasing the generation of ROS. The nonfluor-
escent dichlorofluorescin (DCFH), upon oxidation, is
converted to DCF and emits fluorescence. Because
DCFH can be oxidized by various ROS, the increase of
intracellular DCF fluorescence therefore reflects an
Figure 3 27-OHC activated ER stress. Western blots showing an increase in levels of caspase 12 (a) and gadd153 (b), two specific markers of
ER stress. (c) Immunocytochemistry shows that gadd153 immunorectivity (green) is localized in nucleus (DAPI, blue) following treatment with
27-OHC (arrows). *p < 0.05, **p < 0.01 vs control; Bar, 20 μm.
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that 27-OHC increased DCFH fluorescence, indicating
that treatment with this oxysterol can generate ROS in
ARPE-19 cells (Figure 5b). Excessive production of ROS
is known to lead to oxidative stress, loss of cell function,
and ultimately to cell death. Treatment of cells with
25 μM 27-OHC but not 10 μM concentration increased
HO-1 (Figure 5c).
27-OHC induced cell death
After 24 hrs treatment, the effect of 27-OHC on cell
viability was quantitatively determined by the measure-
ment of lactate dehydrogenase (LDH) released from
cells into the medium by using the CytoTox-ONE™
Homogeneous Membrane Integrity Assay. LDH is
released into the surrounding medium from cells that
have lost membrane integrity. This fluorometric assay
estimates the number of nonviable cells by measuring
the release of LDH from cells with a damaged mem-
brane. The amount of fluorescence produced is propor-
tional to the number of lysed cells. Our results showed
that 27-OHC treatment leads to a significant increase in
the number of dead cells (Figure 6a). Cell death involves
various events including the loss of mitochondrial mem-
brane potential [39]. The fluorescent cationic dye JC-1
(5, 5′,6 ,6 ′-tetrachloro-1,1′,3,3′ tetraethylbenzimidazolyl-
carbocyanine iodide) was used in our experiments that
signals the loss of mitochondrial membrane potential
[40]. In apoptotic cells, JC-1 exists in the green fluores-
cent (529 nm) monomeric form because of decreased
mitochondrial membrane potential. In non-apoptotic
cells, JC-1 accumulates as aggregates in the mitochon-
drial membranes, resulting in red fluorescence (590 nm)
[41]. The ratio of red to green fluorescence was deter-
mined. Our results show that 10 μMa n d2 5μM
27-OHC reduces the red: green ratio, indicating a
decrease in the mitochondrial membrane potential
(Figure 6b). TUNEL assay, used to detect apoptotic cell
death, showed no TUNEL-positive cells in untreated
cells; in the 27-OHC-treated cells, TUNEL-positive cells
were observed with a number that is higher with 25 μM
than 10 μM 27-OHC (Figure 6c). All together, these
results demonstrate that 27-OHC compromises cell
survival.
Discussion
Epidemiological studies show that increased plasma cho-
lesterol levels are associated with atherosclerosis and
increased risk of dementia, including AD [17,42].
Although, there is no consensus on the association of
Figure 4 Effects of 27-OHC on TNF-a levels and NFB. Treatment with 27-OHC increases TNF-a levels, as shown by ELISA (a) and increased
NFB levels in the nucleus as shown by Western blot (b). Immunocytochemistry for NFB shows increased immunoreactivity (green) and
translocation into the nucleus (DAPI, blue) of this protein in the 27-OHC-treated cells (arrows, c). *p < 0.05 vs control; Bar, 20 μm.
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Page 7 of 12Figure 5 27-OHC effects on glutathione, ROS and HO-1. Treatment with 27-OHC causes a decrease in glutathione concentrations (a), an
increase in ROS generation as measured by DCFH-DA assay (b) and an increase in HO-1 levels (c). *p < 0.05, **p < 0.01 vs control.
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association studies implicated cholesterol metabolism
involvement in AMD [43,44]. Drusen on Bruch’sm e m -
branes in AMD exhibit increased deposition of lipids,
including cholesterol. The origin of lipids that accumu-
late in these structures has been a source of debate,
with studies suggesting intraocular source and/or plasma
contribution to lipid accumulation in the eye (see for
review [45]). It is also possible that cholesterol oxidized
metabolites (oxysterols) in plasma can gain access to the
eye. Similar access of plasma oxysterols to the brain has
been reported [46]. It is also possible that locally made
cholesterol in the eye is associated with increased levels
of oxysterols in certain conditions. As an example, sterol
27-hydroxylase (CYP27A1)-the enzyme that converts
cholesterol to 27-OHC has been shown to localize in
retina [22,47]. It is known that deficiency in 7-a-hydro-
xylase, an enzyme needed to prevent 27-OHC accumu-
lation, causes severe neonatal cholestatic liver disease,
where 27-OHC concentrations in the plasma could
reach up to 800 μM [48]. Similar abnormal accumula-
tion of these metabolites in the retina may put this
tissue in danger of degeneration. Of these oxysterols,
7-ketocholesterol has been suggested to play a key role
in the pathogenesis of AMD [25] and has been recently
shown to induce DNA damage in human RPE cells [49].
Other oxysterols such as 24-OHC, 25-OHC, 27-OHC,
and 7b-OHC triggered inflammation, induced oxidative
stress and apoptotic cell death [32,50-53] in various
cells. However, further studies are warranted to measure
oxysterols in the eyes of hypercholesterolemic animals
or humans.
Mounting evidence demonstrates that oxysterols have
deleterious effects that may contribute to the pathogen-
esis of AD and AMD. However, the intracellular mechan-
isms underlying oxysterols toxicity are not well known.
A common pathological feature that accumulates both in
AD and AMD is Ab [8,9], a peptide that is considered to
play a central role in the neurodegenerative processes by
increasing oxidative stress and cell damage. We have
recently shown that 27-OHC, but not 24-OHC, increases
Ab peptide levels in human neuroblastoma cells [13] and
in rabbit hippocampus [15]. In the present study, we
demonstrate for the first time that 27-OHC also increases
the levels of Ab in retinal pigment epithelium ARPE-19
cells. Ab deposition could be an important element in
the local inflammatory and oxidative processes that con-
tribute to the deterioration of photoreceptors and patho-
genesis of AMD. The b-amyloid precursor protein is
present in the RPE cytoplasm and Ab-labeled structures
Figure 6 27-OHC is deleterious to ARPE-19 cells. A Cyto Tox-ONE Homogenous membrane integrity assay shows that 27-OHC is cytotoxic to
cells (a) and decreases the mitochondrial membrane potential as measured by a reduction in red (non-apoptotic cells)/green (apoptotic cells)
fluorescence (b). TUNEL assay shows that 27-OHC increases the number of apoptotic cells (arrow) with 25 μM 27-OHC (c). Apoptosis is evidenced
by DNA fragmentation labeled with fluorescein (green); Propidium iodide (red) is used to label cell nuclei. **p < 0.01 vs control, Bar, 20 μm.
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cells have the ability to generate Ab. Our results show
that Ab accumulation at least in part is due to increased
generation of this peptide by the action of BACE-1, the
enzyme that initiates the cleavage of b-amyloid precursor
protein.
Accumulation of Ab and oxidative damage are intrin-
sically related. Oxidative damage in cells can be caused
by a variety of factors including ER stress, ROS genera-
tion, glutathione depletion and inflammation. ER stress
has been implicated in both AD (see for review [54])
and AMD (see for review [55]). The ER is the cell com-
partment where various proteins are synthesized and
Ca
2+ is stored. Cellular stress leads to depletion of ER
Ca
2+ stores, activation of specific ER stress proteins
such as caspase 12, gadd153 and apoptotic cell death
[56]. Our results show that 27-OHC-induced ER stress
m a yb ed u et ot h el o s so fC a
2+ influx and a decrease in
ER Ca
2+ levels. This was consistent since 27-OHC
showed activation of the ER specific apoptotic proteins
caspase 12 and gadd153. Gadd153 is present in the cyto-
sol under normal conditions and translocates to the
nucleus following sustained ER stress [57]. Induction of
gadd153 was shown to upset the cellular redox state by
depleting cellular glutathione and exaggerating the pro-
duction of ROS [58]. We also showed that the 27-OHC-
induced gadd153 activation is accompanied by increased
levels of ROS and depleted glutathione.
HO-1 is mainly located in the ER and stimulates the
oxidation of cholesterol to oxysterols. It is regarded as a
sensitive marker of oxidative stress in cells and tissues
[59,60]. Its induction is suggested to be an early event in
the pathogenesis of sporadic AD [61]. HO-1 levels were
also increased in RPE of AMD-affected maculas [62].
HO-1 gene expression is stimulated by ER stress [63].
ER stress can also cause apoptosis via NFB activation
[64]. In a basal state, NFB is sequestered in the cyto-
plasm by IB protein. ER stress and ROS degrade IB,
leading NFB translocation to the nucleus where NFB
induces transcription of target genes. Activation of
NFB was observed in AD [65] as well as in AMD [66].
Our results showed that 27-OHC increases levels of
HO-1 and activated NFB. This suggests the potential
role of 27-OHC as a pro-oxidant that can cause oxida-
tive damage to retinal cells and in the pathophysiology
of AMD.
Increased levels of Ab,E Rs t r e s s ,H O - 1a n dN F Ba r e
accompanied by glutathione depletion as well as elevated
levels of ROS. These results demonstrate the potential
oxidative effects of 27-OHC. Increased levels of TNF-a
suggest that 27-OHC-induced oxidative stress is asso-
ciated with triggering of inflammatory processes. All
together, oxidative stress and inflammation may ulti-
mately lead to cell death. Our study further demonstrates
that 27-OHC is cytotoxic to cells, induces the loss of
mitochondrial membrane potential and causes apoptotic
cell death as detected by the TUNEL assay.
While it provides important information on the dele-
terious effects of 27-OHC effects in retinal pigment
epithelial, this study has some limitations. For example,
the extent to which the effects we show here are limited
to 27-OHC remains to be investigated as the effects of
other structurally similar oxysterols, such as 24-OHC,
25-OHC or 27-hydroxy-7-ketocholesterol have not been
determined. Additionally, the concentrations of 27-OHC
and other oxysterols are not known in healthy or dis-
eased retinas. The concentrations used for 27-OHC here
were based on concentrations cited in literature for var-
ious oxysterols as well as from our recent studies in
neuroblastoma cells and organotypic slices. Oxysterol
internalization assessment, which would allow an assess-
ment of the actual concentrations that reach the cyto-
plasm were not carried out. Future studies comparing
the effects of 27-OHC to other oxysterols and assessing
their internalization are warranted in order to determine
whether the effects we observed are physiological and
are specific to 27-OHC.
Conclusions
In summary, our study demonstrates that 27-OHC is
deleterious to retinal pigment epithelial cells by trigger-
ing the accumulation of Ab peptide, ER stress and oxi-
dative damage, which are all pathological hallmarks of
both AD and AMD. Our data suggests that 27-OHC
may be a common factor that contributes to the patho-
genesis of both AD and AMD. Preventing excess oxida-
tion of cholesterol to 27-OHC and/or reducing the
accumulation of 27-OHC would probably preclude the
risk of oxidative damage to brain and retinal epithelial
cells.
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